Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UIC chemists identify compound that inhibits cell migration

23.10.2002


A high-throughput assay developed by University of Illinois at Chicago chemists has led to discovery of a small organic compound that shows the unusual ability to inhibit cell migration. The new compound, identified as UIC-1005, may play a role in developing new kinds of cancer drugs.



The findings are published in the November issue of the journal ChemBioChem.

"We’ve been looking for chemical compounds that slow the process of cell migration," said Gabriel Fenteany, assistant professor of chemistry and the study’s principal author. "The process is poorly understood and has a lot of therapeutic potential."


Fenteany is also part of the UIC Cancer Center.

Fenteany and his co-workers grow skin-like epithelial cell sheets on tissue culture plates with many small depressions, or wells, each of which contains a culture of cells and a different chemical compound, providing the basis for the assay.

"We grow these cells and make little scratches in the resulting sheet of cells," Fenteany said. "A little gap forms, and cells move in to close that gap, similar to part of the wound healing process when you cut yourself.

"The process is also related to how a cancer cell will start to move to form a metastasis, and to how a tumor will recruit new blood vessels, which helps it grow," Fenteany said. "The phenomenon of cell shape change and movement is universal, even though details differ on how these cells move in different situations."

The assay developed by the UIC chemists makes the process to find molecules that inhibit cell movement quick and easy.

"We can easily screen a thousand compounds a day, or more," Fenteany said, adding, "We’re one of the few labs doing these sorts of screens. Therefore, there’s not really a good sense of what sorts of compounds will inhibit the process. That’s what we’re looking at."

Fenteany and his colleagues began their search using the high-throughput assay in December 2000 and discovered UIC-1005 a few months later. The new compound is from a class of molecules called oxazolidinones, which in recent years have been used successfully to develop new antibiotics that kill bacteria now resistant to older drugs. UIC-1005, however, shows no anti-bacterial properties and acts differently.

Fenteany hopes other labs adopt this high-throughput assay to hasten the discovery of additional molecules that inhibit cell migration. That search continues at UIC, along with work to modify the compound UIC-1005.

"Once you find the active structure, you can modify that structure to improve its activity, find out what it binds in the cell, and how," Fenteany said. "We’re working to find the protein it binds, and we have a candidate. Since the small molecule targets the protein and inhibits the process of cell movement, the protein becomes a potential target for drug development to block the pathway during disease."

Fenteany predicts drugs that inhibit cell migration may prove effective in combination therapies against cancer.

"A person who has had a tumor removed through surgery still faces the problem that some cancer cells escaped. By taking a cocktail of drugs, including anti-migratory compounds like UIC-1005 and other compounds we’ve yet to discover, the cancer could be more effectively contained. So even if not every cancer cell was removed by surgery or controlled in traditional chemotherapy, you’ve limited the ability of cells to move and spread and start new tumors."


Other authors are Arun Ghosh, professor of chemistry, and researchers Kevin McHenry and Sudha Ankala, all of UIC.

Funding for this research was by grants from UIC and the National Cancer Institute. Ongoing research is supported by a new grant from the American Cancer Society

Paul Francuch | EurekAlert!

More articles from Life Sciences:

nachricht Single-stranded DNA and RNA origami go live
15.12.2017 | Wyss Institute for Biologically Inspired Engineering at Harvard

nachricht New antbird species discovered in Peru by LSU ornithologists
15.12.2017 | Louisiana State University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>